RIGEL PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RIGEL PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2018 was $67.16M, a 41.18% decline from fiscal 2017.
- RIGEL PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2017 was $114.18M, a 387.82% increase from fiscal 2016.
- RIGEL PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2016 was $23.41M, a 327.74% increase from fiscal 2015.
- RIGEL PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2015 was $5.47M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2018-12-31 | $67.16M 10-K · filed 2021-03-02 | |
| 2017-12-31 | $114.18M 10-K · filed 2020-02-27 | |
| 2016-12-31 | $23.41M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $5.47M 10-K · filed 2018-03-06 | |
| 2012-12-31 | $135.73M 10-K · filed 2015-03-03 | |
| 2011-12-31 | $140.50M 10-K · filed 2014-03-04 | |
| 2010-12-31 | $0.00 10-K · filed 2012-03-06 | |
| 2009-12-31 | $101.46M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |